Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

ADA CONFERENCE: Muse Achieves 60% Efficacy In Diabetic Men MOUNTAIN VIEW, CA -- June 16, 1998 -- An independent study shows that Vivus, Inc.’s Muse(R) (alprostadil) achieved a 60 percent efficacy rate in diabetic men with erectile dysfunction. The abstract was presented at the American Diabetes Association annual meeting in Chicago which concluded today. The 230 person study included 65 diabetic and 165 non-diabetic men with erectile dysfunction who received Muse for up to six months. Prior to Muse dosing, patients had a 30 to 45 minute counselling session that included a video on the proper administration of Muse. The treatment was deemed successful when patients completed sexual intercourse on two or more occasions. The researchers reported that 60 percent of the diabetic patients had success compared to 54 percent of non-diabetic patients. It is estimated that half of the approximately four million men with diabetes mellitus in the United States will experience erectile dysfunction. "Muse is a good treatment option for men with diabetes and/or vascular disease especially because it has few systemic side effects," said Kenneth Snow, MD, medical director of the Joslin-Lahey Diabetes & Endocrinology Center in Peabody, MA and a lead investigator in this trial. The authors also concluded that Muse appears to be more effective in men over the age of 50 and perhaps more effective in men with organic risk factors, as opposed to psychological factors. Approximately 80 percent of all cases of erectile dysfunction are believed to have a physiological origin. The investigators also noted that patient education is critical to the success of the treatment. More information on: Muse, Vivus, Inc. E-mail this page to a friend or colleague! To print, use this version